Breast Pumping for Preterm Birth
(PUMMPP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the optimal frequency for mothers of preterm infants to use a breast pump to increase milk supply. The goal is to determine if breast milk production varies when mothers pump every 2 hours versus every 3 hours. Participants will record their milk output daily for the first 28 days of their baby's life. Mothers with preterm babies born at less than 32 weeks or weighing under 1500 grams may be suitable for this study. As an unphased trial, this study provides mothers the opportunity to contribute to important research that could enhance care for preterm infants.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that this breast-pumping protocol is safe for mothers of preterm infants?
Research shows that breast pumping is generally safe for mothers of premature babies. Hospitals often suggest pumping every 2-3 hours to help mothers produce more milk. Studies have found that pumping is common for mothers with early-born babies because it can increase milk supply, which is important for the baby's nutrition.
Specific data does not show safety issues with pumping every 2 hours compared to every 3 hours. However, using a breast pump is a well-known way to express milk, and serious problems are rare. This trial examines how different pumping schedules affect milk quantity, not safety concerns.
Overall, breast pumps are considered safe and are widely used by mothers in similar situations. Prospective participants can feel confident that pumping is a standard, safe practice. This study simply explores the best schedule to help increase milk production.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores different breast pumping schedules to boost milk production for mothers of preterm infants. Unlike standard practices that might not have a set pumping frequency, this study examines the effects of pumping every 2 hours versus every 3 hours. The potential for increased milk supply with more frequent pumping could offer critical benefits for the nutrition and immunity of preterm babies, providing them with the vital nutrients they need to thrive. By identifying an optimal pumping schedule, this trial could help improve outcomes for both mothers and their newborns.
What evidence suggests that this pumping method is effective for increasing breast milk supply in mothers of preterm infants?
Research has shown that more frequent breast milk pumping can help mothers of premature babies produce more milk. In this trial, participants will follow different pumping schedules. Studies have found that pumping every 2 hours, one of the schedules tested in this trial, often results in more milk than less frequent pumping. Frequent pumping mimics a baby's natural feeding pattern, which encourages milk production. The trial aims to increase milk supply by regularly stimulating the breasts. While results can vary for each person, more frequent pumping generally leads to better milk production for mothers with preterm infants.
Are You a Good Fit for This Trial?
This trial is for mothers with preterm infants born before 32 weeks gestation or weighing less than 1500 grams at birth. It's also open to those transferred to the facility within 48 hours of life. Participants must have legal consent from parents or guardians.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are assigned to pump every 2 or 3 hours and record breastmilk volume for 28 days
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Pumping to Up Maternal Milk Production
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor